Type
Business expansion
Country
France
Region
Bassin Parisien; Centre; Eure-et-Loir
Location of affected unit(s)
Chartres
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.20 - Manufacture of pharmaceutical preparations

250 jobs
Number of planned job creations
Job creation
Announcement Date
9 December 2016
Employment effect (start)
1 December 2016
Foreseen end date
31 December 2020

Description

The management of the French subsidiary of the Danish pharmaceutical group Novo Nordisk, has announced to create about 250 position in the next four years on its site of Chartres (Eure-et-Loire) to sustain its growth. The Danish company employs currently 1,100 employees in Chartres. Over the past 15 years, it has invested €300 million on the site and hired 400 employees between 2012 and 2015. Novo distributes 13% of its production on the French market and in 2017 plans to launch a new molecule against diabetes as well as a new generation of injectable pens to support its market growth.


Sources

  • 9 December 2016: L'Echo républicain

Citation

Eurofound (2016), Novo Nordisk Production, Business expansion in France, factsheet number 89673, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/89673.